TrialStroke2026

Predictors of Hematoma Expansion and Response to Andexanet in Patients With Intracerebral Hemorrhage: Secondary Analyses of the ANNEXA-I Randomized Clinical Trial.

Ashkan Shoamanesh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.